Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Gawel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|June 15, 2005
Intranasal zolmitriptanMarek Gawel, Irene Worthington
Current Pain and Headache Reports|March 2, 2002
Triptans: are they all the same?Tamara Pringsheim, Marek Gawel
Drugs|October 4, 2003
Newer formulations of the triptans: advances in migraine managementJonathan Paul Gladstone, Marek Gawel
The Journal of Headache and Pain|December 20, 2005
Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE studyMarek Gawel, Jürgen Aschoff, Arne May, et al.
Headache|January 25, 2005
Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE StudyMarek Gawel, Jürgen Aschoff, Arne May, et al.
Pharmacoeconomics|August 16, 2005
An economic evaluation of rizatriptan in the treatment of migraineMelissa Thompson, Marek Gawel, Brigitte Desjardins, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Are statin medications safe in patients with ALS?Lorne Zinman, Reza Sadeghi, Marek Gawel, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 8, 2007
Migraine treatmentWerner J Becker, Marek Gawel, Gordon Mackie, et al.
Headache|October 23, 2002
A headache diagnosis projectWilliam Pryse-Phillips, Michel Aubé, Marek Gawel, et al.
Headache|April 21, 2007
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory studySheena K Aurora, Marek Gawel, Jan L Brandes, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|June 15, 2005
Intranasal zolmitriptanMarek Gawel, Irene Worthington
Current Pain and Headache Reports|March 2, 2002
Triptans: are they all the same?Tamara Pringsheim, Marek Gawel
Drugs|October 4, 2003
Newer formulations of the triptans: advances in migraine managementJonathan Paul Gladstone, Marek Gawel
The Journal of Headache and Pain|December 20, 2005
Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE studyMarek Gawel, Jürgen Aschoff, Arne May, et al.
Headache|January 25, 2005
Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE StudyMarek Gawel, Jürgen Aschoff, Arne May, et al.
Pharmacoeconomics|August 16, 2005
An economic evaluation of rizatriptan in the treatment of migraineMelissa Thompson, Marek Gawel, Brigitte Desjardins, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Are statin medications safe in patients with ALS?Lorne Zinman, Reza Sadeghi, Marek Gawel, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 8, 2007
Migraine treatmentWerner J Becker, Marek Gawel, Gordon Mackie, et al.
Headache|October 23, 2002
A headache diagnosis projectWilliam Pryse-Phillips, Michel Aubé, Marek Gawel, et al.
Headache|April 21, 2007
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory studySheena K Aurora, Marek Gawel, Jan L Brandes, et al.
Pageof 2